A Preview Of ScPharmaceuticals's Earnings
A Preview Of ScPharmaceuticals's Earnings
scPharmaceuticals (NASDAQ:SCPH) is set to give its latest quarterly earnings report on Wednesday, 2024-03-13. Here's what investors need to know before the announcement.
SCPHarmicals(納斯達克股票代碼:SCPH)定於2024-03-13星期三發佈其最新的季度收益報告。以下是投資者在宣佈之前需要了解的內容。
Analysts estimate that scPharmaceuticals will report an earnings per share (EPS) of $-0.42.
分析師估計,SCPharmicals將公佈的每股收益(EPS)爲-0.42美元。
scPharmaceuticals bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
SCPharmicals的多頭希望聽到該公司宣佈他們不僅超過了這一預期,而且爲下一季度提供積極的指導或預測的增長。
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
新投資者應注意,有時對股票價格影響最大的不是收益超過或失敗,而是指導方針(或預測)。
Past Earnings Performance
過去的收益表現
Last quarter the company missed EPS by $0.05, which was followed by a 8.74% drop in the share price the next day.
上個季度,該公司每股收益低於0.05美元,隨後第二天股價下跌8.74%。
Here's a look at scPharmaceuticals's past performance and the resulting price change:
以下是scPharmicals過去的表現以及由此產生的價格變化:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | -0.36 | -0.37 | -0.36 | -0.39 |
EPS Actual | -0.41 | -0.36 | -0.30 | -0.27 |
Price Change % | -9.0% | 1.0% | -1.0% | 25.0% |
季度 | 2023 年第三季度 | 2023 年第二季度 | 2023年第一季度 | 2022 年第四季度 |
---|---|---|---|---|
每股收益估算 | -0.36 | -0.37 | -0.36 | -0.39 |
實際每股收益 | -0.41 | -0.36 | -0.30 | -0.27 |
價格變動% | -9.0% | 1.0% | -1.0% | 25.0% |
Stock Performance
股票表現
Shares of scPharmaceuticals were trading at $5.28 as of March 11. Over the last 52-week period, shares are down 24.53%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
截至3月11日,SCPharmicals的股票交易價格爲5.28美元。在過去的52週中,股價下跌了24.53%。鑑於這些回報率通常爲負數,長期股東在發佈本業績時可能會感到沮喪。
To track all earnings releases for scPharmaceuticals visit their earnings calendar on our site.
要追蹤SCPharmicals發佈的所有業績,請訪問我們網站上的業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成,並由編輯審閱。
譯文內容由第三人軟體翻譯。